CAELUM BIOSCIENCES, INC.

Profile

Company Names

CAELUM BIOSCIENCES, INC.

Addresses

2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY 10014

Phone Numbers

781-652-4500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$18,714,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2017-09-15 
$9,914,000.00 
$10,000,000.00 
$86,000.00 
Debt 
2
2017-08-31 
$7,800,000.00 
$10,000,000.00 
$2,200,000.00 
Debt 
1
2017-07-31 
$1,000,000.00 
$7,000,000.00 
$6,000,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH 
W. 
CAPPELL 
DIRECTOR
HELOCYTE, INC.   |  CAELUM BIOSCIENCES, INC.
MARTIN 
 
GOLDMAN 
DIRECTOR
CAELUM BIOSCIENCES, INC.
DAVID 
 
HORIN 
EXECUTIVE OFFICER
RODMAN + RENSHAW CAPITAL GROUP, INC.   |  TRIG ACQUISITION 1, INC   |  LIFE CARE MEDICAL DEVICES LTD   |  SPENDSMART PAYMENTS CO   |  CAELUM BIOSCIENCES, INC.
WILLIAM 
 
NATBONY 
DIRECTOR
ELECTRUM STRATEGIC ACQUISITIONS LLC   |  TIGRIS PARTNERS I LLC   |  ELECTRUM STRATEGIC METALS II LLC   |  ELECTRUM GLOBAL HOLDINGS L.P.   |  TEG SERVICES HOLDING INC.   |  ELECTRUM GROUP LTD.   |  CAELUM BIOSCIENCES, INC.   |  EDGESTREAM SUMATRA FUND, LP   |  EDGESTREAM NIAS FUND, LTD.   |  EDGESTREAM EXTENDED TACTICAL FUTURES FUND, L.P.   |  EDGESTREAM EXTENDED TACTICAL FUND, LTD.   |  EDGESTREAM EXTENDED TACTICAL FUND, L.P.
JEFFREY 
 
PALEY 
DIRECTOR
KALYTERA THERAPEUTICS, INC.   |  CAELUM BIOSCIENCES, INC.
LINDSAY 
A. 
ROSENWALD 
DIRECTOR
CORONADO BIOSCIENCES INC   |  OPUS POINT HEALTHCARE INNOVATIONS FUND, L.P.   |  CB PHARMA ACQUISITION CORP.   |  CHECKPOINT THERAPEUTICS, INC.   |  HELOCYTE, INC.   |  MUSTANG BIO, INC.   |  FORTRESS BIOTECH, INC.   |  CAELUM BIOSCIENCES, INC.   |  CYPRIUM THERAPEUTICS, INC.
MICHAEL 
 
SPECTOR 
EXECUTIVE OFFICER, DIRECTOR
UNDISPUTED BOXING, INC.   |  CAELUM BIOSCIENCES, INC.
MICHAEL 
S. 
WEISS 
DIRECTOR
OPUS POINT HEALTHCARE INNOVATIONS FUND, L.P.   |  CB PHARMA ACQUISITION CORP.   |  OPUS POINT HEALTHCARE INNOVATIONS (OFFSHORE) FUND LTD.   |  CHECKPOINT THERAPEUTICS, INC.   |  HELOCYTE, INC.   |  MUSTANG BIO, INC.   |  FORTRESS BIOTECH, INC.   |  CAELUM BIOSCIENCES, INC.   |  URICA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-09-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-09-15 
2017-09-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-08-31 
2017-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-07-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NATIONAL SECURITIES CORPORATION
7569
NATIONAL SECURITIES CORPORATION
7569